MedPath

An electronic nose in the screening for COPD in an at risk population of (ex-)smokers.

Completed
Conditions
COPD, smoking
Registration Number
NL-OMON20180
Lead Sponsor
Academic Medical CenterUniversity of AmsterdamDept. Pulmonology, F5-260Meibergdreef 91105 AZ AmsterdamThe NetherlandsUniversity Medical Center UtrechtUniversity of UtrechtDept. PulmonologyHeidelberglaan 1003584 CX UtrechtThe NetherlandsThe Nelson Study Group (Nederlands-Leuvens Longkanker Screeningsonderzoek).
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
250
Inclusion Criteria

1. > 40 years

2. Smoking or ex-smoking

Exclusion Criteria

1. Failure to complete eNose measurement

2. Not willing to participate in the study or lack of understanding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Electronic nose smellprint of a vital capacity volume breath sample.<br>
Secondary Outcome Measures
NameTimeMethod
- Pre- and postbronchodilator spirometry according to ERS/ATS recommendations.<br /><br>- CO diffusion capacity according to ERS/ATS recommendations<br /><br>- Spiral CT scan of the thorax: presence and extent of emphesema<br /><br>- Questionnaires to assess symptoms of COPD, co-morbidity and smoking status.
© Copyright 2025. All Rights Reserved by MedPath